Reposal
Clinical data | |
---|---|
ATC code | N05CA12 (WHO) |
Identifiers | |
| |
Synonyms | Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid |
CAS Number | 3625-25-0 |
PubChem (CID) | 19254 |
ChemSpider | 10468690 |
ChEMBL | CHEMBL505851 |
Chemical and physical data | |
Formula | C14H18N2O3 |
Molar mass | 262.304 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1][2][3]
References
- ↑ Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. I. Pharmacodynamic Activity". Ugeskrift for laeger (in Danish). 125: 1735–1738. PMID 14103836.
- ↑ Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. II. Clinical Effects". Ugeskrift for laeger (in Danish). 125: 1739–1741. PMID 14103837.
- ↑ Nielsen, P.; Tarding, F. (1968). "The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal)". Acta pharmacologica et toxicologica. 26 (6): 521–530. doi:10.1111/j.1600-0773.1968.tb00471.x. PMID 5756387.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.